ARDS, acute respiratory distress syndrome; CI, confidence interval; RR, relative risk.
References
 
[1]    D.S. Hui, I.A. E, T.A. Madani, F. Ntoumi, R. Kock, O. Dar, et al., The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China, Int. J. Infect. Dis. 91 (2020) 264–266, https://doi.org/10.1016/j.ijid.2020.01.009 Epub 2020 Jan 14.
[2]    World Health Organization Coronavirus disease (COVID-19), Situation Report - 103 (Accessed 2 May 2020), https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200502-covid-19-sitrep-103.pdf?sfvrsn=d95e76d8_4.
[3]    S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn,
K.W. Davidson, et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA 22 (2020) e206775, , https://doi.org/10.1001/jama.2020.6775.
[4]     Ricardo J. Jose, et al., COVID-19 cytokine storm: the interplay between in- flammation and coagulation, Lancet Respir Med 27 (2020) S2213-2600(20) 30216-2.
[5]     V.M. Ranieri, G.D. Rubenfeld, B.T. Thompson, et al., ARDS definition task force. Acute respiratory distress syndrome: the Berlin denition, JAMA 307 (23) (2012) 2526–2533.
[6]    J. Yang, Y. Zheng, X. Gou, K. Pu, Z. Chen, Q. Guo, et al., Prevalence of comorbidities
in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int. J. Infect. Dis. 94 (2020) 91–95, https://doi.org/10.1016/j.ijid.
2020.03.017.
[7]    S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn,
K.W. Davidson, et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA (2020), https://doi.org/10.1001/jama.2020.6775.
[8]    D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA (2020), https://doi.org/10.1001/jama.2020.1585.
[9]    Q. Ruan, K. Yang, W. Wang, L. Jiang, J. Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care 46 (5) (2020) 846–848.
[10]      A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, D.E. Singer,
Prevalence of diagnosed atrialbrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study, JAMA 285 (18) (2001) 2370–2375.
[11]    N. Tang, D. Li, X. Wang, Z. Sun, Abnormal coagulation parameters are associated
with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost 18 (4) (2020) 844–847.
[12]    P. Di Micco, V. Russo, N. Carannante, M. Imparato, S. Rodolfi, G. Cardillo,
C. Lodigiani, Clotting factors in COVID-19: epidemiological association and prog- nostic values in different clinical presentation among Italian cohort study, J Clin Med. 9 (5) (2020), https://doi.org/10.3390/jcm9051371 pii: E1371.